CEVEC PHARMACEUTICALS GMBH has a total of 107 patent applications. It increased the IP activity by 86.0%. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, foods and drinks and pharmaceuticals are BIOSOURCE TECH INC, NEUWAY PHARMA GMBH and CMC ICOS BIOLOGICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 19 | |
#2 | Australia | 10 | |
#3 | WIPO (World Intellectual Property Organization) | 9 | |
#4 | Canada | 8 | |
#5 | China | 8 | |
#6 | Republic of Korea | 8 | |
#7 | Singapore | 8 | |
#8 | United States | 8 | |
#9 | Brazil | 7 | |
#10 | Israel | 6 | |
#11 | Germany | 3 | |
#12 | Hungary | 2 | |
#13 | Mexico | 2 | |
#14 | Taiwan | 2 | |
#15 | South Africa | 2 | |
#16 | Czechia | 1 | |
#17 | Hong Kong | 1 | |
#18 | Malaysia | 1 | |
#19 | Poland | 1 | |
#20 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks | |
#3 | Pharmaceuticals | |
#4 | Measurement | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Fermentation | |
#4 | Enzymes | |
#5 | Therapeutic chemical compounds | |
#6 | Medical preparations | |
#7 | Analysing materials | |
#8 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Wissing Silke | 50 |
#2 | Schiedner Gudrun | 42 |
#3 | Faust Nicole | 42 |
#4 | Wölfel Jens | 21 |
#5 | Volpers Christoph | 16 |
#6 | Hein Kerstin | 10 |
#7 | Kewes Helmut | 9 |
#8 | Strempel Nikola | 9 |
#9 | Ribbert Markus | 8 |
#10 | Kochanek Stefan | 7 |
Publication | Filing date | Title |
---|---|---|
EP3456822A1 | Inducible aav rep genes | |
EP3441471A1 | Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines | |
EP3382014A1 | Recombinant glycoproteins with reduced antennary fucosylation | |
EP3205719A1 | Cell lines for producing recombinant glycoproteins with di-antennary n-glycans, methods using the same, and recombinant glycoproteins | |
EP3042952A1 | O-glycan sialylated recombinant glycoproteins and cell lines for producing the same | |
EP2909228A1 | Production of a hcmv based vaccine in human amniocyte cell lines | |
EP2722337A1 | Production of a HCMV based vaccine in human amniocyte cell lines | |
KR20130097191A | Permanent human amniocyte cell lines for producing influenza viruses | |
DE102009003439A1 | New permanent human cell line | |
DE102005054628A1 | Process for the preparation of permanent human cell lines | |
EP1478389A1 | Treatment for diseases of the eye | |
EP1362096A2 | Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system | |
DE10108412A1 | Pigment epithelial cell of the eye, its preparation and use in the treatment of an ocular or nervous disease |